This page shows Melar Acqsn (MACIU) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores
Melar Acqsn's current ratio of 0.91 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 13/100, which could limit financial flexibility.
For every $1 of reported earnings, Melar Acqsn generates $-0.14 in operating cash flow (-$774K OCF vs $5.5M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Melar Acqsn earns $-2.7 in operating income for every $1 of interest expense (-$1.5M vs $540K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
Melar Acqsn reported $5.5M in net income in fiscal year 2025.
Cash & Balance Sheet
Melar Acqsn held $32K in cash against $0 in long-term debt as of fiscal year 2025.
Margins & Returns
Capital Allocation
MACIU Income Statement
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | N/A | $712K+205.2% | $233K+48.6% | $157K | N/A | $130K+47.2% | $89K |
| Operating Income | N/A | -$712K-205.2% | -$233K-48.6% | -$157K | N/A | -$130K-47.2% | -$89K |
| Interest Expense | N/A | $384K+352011.0% | $109 | N/A | N/A | N/A | N/A |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | N/A | $1.1M-28.7% | $1.6M-1.5% | $1.6M | N/A | $2.4M+2135.1% | $106K |
| EPS (Diluted) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
MACIU Balance Sheet
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|
| Total Assets | $175.3M+0.9% | $173.8M+2.9% | $168.9M+1.1% | $167.1M+0.9% | $165.5M+1.1% | $163.7M+1.4% | $161.5M |
| Current Assets | $3.9M-3.4% | $4.0M+313.7% | $978K+6.7% | $916K-12.2% | $1.0M-5.5% | $1.1M-8.6% | $1.2M |
| Cash & Equivalents | $32K-88.8% | $286K-48.5% | $556K-19.8% | $693K-21.1% | $878K-6.0% | $934K-9.9% | $1.0M |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $182.3M+1.1% | $180.4M+3.2% | $174.8M+1.2% | $172.8M+1.0% | $171.0M+1.1% | $169.1M+1.3% | $166.9M |
| Current Liabilities | $4.3M+5.7% | $4.1M+1292.2% | $292K+788.6% | $33K-20.4% | $41K+263.7% | $11K-92.9% | $160K |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | -$7.0M-5.6% | -$6.6M-11.9% | -$5.9M-4.1% | -$5.7M-2.8% | -$5.5M-2.4% | -$5.4M+0.2% | -$5.4M |
| Retained Earnings | -$7.0M-5.6% | -$6.6M-11.9% | -$5.9M-4.1% | -$5.7M-2.8% | -$5.5M-2.4% | -$5.4M+0.2% | -$5.4M |
MACIU Cash Flow Statement
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$237K-10.0% | -$215K-56.7% | -$137K+25.8% | -$185K-231.5% | -$56K+45.8% | -$103K+73.3% | -$386K |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | -$18K+99.4% | -$3.0M | N/A | N/A | $0 | $0+100.0% | -$160.0M |
| Financing Cash Flow | $0-100.0% | $3.0M | N/A | N/A | $0 | $0-100.0% | $161.4M |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
MACIU Financial Ratios
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | N/A | 0.6%-0.3pp | 0.9%-0.0pp | 0.9% | N/A | 1.5%+1.4pp | 0.1% |
| Current Ratio | 0.91-0.1 | 1.00-2.4 | 3.35-24.6 | 27.91+2.6 | 25.30-72.1 | 97.39+89.9 | 7.54 |
| Debt-to-Equity | -26.09+1.2 | -27.26+2.3 | -29.56+0.8 | -30.40+0.5 | -30.95+0.4 | -31.34-0.5 | -30.86 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Note: Shareholder equity is negative (-$7.0M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.91), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Frequently Asked Questions
Is Melar Acqsn profitable?
Yes, Melar Acqsn (MACIU) reported a net income of $5.5M in fiscal year 2025.
What is Melar Acqsn's operating cash flow?
Melar Acqsn (MACIU) generated -$774K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Melar Acqsn's total assets?
Melar Acqsn (MACIU) had $175.3M in total assets as of fiscal year 2025, including both current and long-term assets.
What is Melar Acqsn's current ratio?
Melar Acqsn (MACIU) had a current ratio of 0.91 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is Melar Acqsn's debt-to-equity ratio?
Melar Acqsn (MACIU) had a debt-to-equity ratio of -26.09 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Melar Acqsn's return on assets (ROA)?
Melar Acqsn (MACIU) had a return on assets of 3.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Melar Acqsn's cash runway?
Based on fiscal year 2025 data, Melar Acqsn (MACIU) had $32K in cash against an annual operating cash burn of $774K. This gives an estimated cash runway of approximately 0 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
Why is Melar Acqsn's debt-to-equity ratio negative or unusual?
Melar Acqsn (MACIU) has negative shareholder equity of -$7.0M as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
Are Melar Acqsn's earnings high quality?
Melar Acqsn (MACIU) has an earnings quality ratio of -0.14x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Melar Acqsn cover its interest payments?
Melar Acqsn (MACIU) has an interest coverage ratio of -2.7x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Melar Acqsn?
Melar Acqsn (MACIU) scores 2 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.